Cardiovascular clinical trials in the era of a pandemic.
J Am Heart Assoc
; 9(20): e018288, 2020 10 20.
Article
in English
| MEDLINE | ID: covidwho-1255742
ABSTRACT
COVID-19 has reached pandemic levels in March 2020 and impacted public health with unpredictable consequences.1, 2 The conduct of clinical research in areas unrelated to COVID-19 has been disrupted and will be further affected. Researchers, trial participants and study personnel have to overcome challenges to sustain proper and safe conduct of clinical trials (i.e. logistical challenges, lower enrollment than expected, difficulties in follow-up and outcome assessment/adjudication, incomplete data collection, research funding prolongation).
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Cardiovascular Diseases
/
Randomized Controlled Trials as Topic
/
Coronavirus Infections
/
Pandemics
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
J Am Heart Assoc
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS